WINTON GROUP Ltd Makes New $1.31 Million Investment in Cigna Group $CI

WINTON GROUP Ltd purchased a new stake in Cigna Group (NYSE:CI) in the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 4,760 shares of the health services provider’s stock, valued at approximately $1,312,000.

A number of other institutional investors and hedge funds have also bought and sold shares of CI. California State Teachers Retirement System grew its position in shares of Cigna Group by 26,190.2% in the 2nd quarter. California State Teachers Retirement System now owns 106,647,359 shares of the health services provider’s stock valued at $29,400,544,000 after buying an additional 106,241,705 shares during the last quarter. BlackRock Inc. lifted its stake in shares of Cigna Group by 3.7% in the second quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock worth $6,461,457,000 after acquiring an additional 840,098 shares during the period. State Street Corp boosted its holdings in Cigna Group by 1.8% in the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock valued at $3,396,132,000 after acquiring an additional 224,122 shares during the last quarter. Dodge & Cox increased its position in Cigna Group by 19.7% during the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after purchasing an additional 1,833,389 shares during the period. Finally, GQG Partners LLC lifted its position in shares of Cigna Group by 14.3% in the 4th quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock worth $2,136,699,000 after purchasing an additional 972,302 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CI has been the subject of several recent analyst reports. Wall Street Zen cut shares of Cigna Group from a “buy” rating to a “hold” rating in a research report on Saturday. UBS Group upped their target price on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research report on Friday, May 22nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a report on Thursday, August 27th. Sanford C. Bernstein lifted their price objective on shares of Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Finally, Morgan Stanley raised their price target on shares of Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. Fifteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $337.10.

Insider Buying and Selling

In other Cigna Group news, insider Everett Neville sold 617 shares of the stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the sale, the insider owned 5,053 shares in the company, valued at $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,677 shares of Cigna Group stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the transaction, the insider owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,730 shares of company stock worth $6,293,359 over the last 90 days. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Price Performance

Shares of NYSE CI opened at $280.51 on Friday. The stock has a market cap of $74.12 billion, a price-to-earnings ratio of 11.61, a PEG ratio of 0.96 and a beta of 0.31. The firm’s 50-day simple moving average is $283.31 and its 200 day simple moving average is $280.78. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business’s revenue was up 6.7% on a year-over-year basis. During the same period last year, the business earned $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts anticipate that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio is 25.82%.

About Cigna Group

The Cigna Group (NYSE: CI) is a global health services company that helps individuals, employers, health plans and government organizations access health care and related services. The company operates primarily through two businesses: Cigna Healthcare, which provides medical, behavioral health, dental and other health benefit products and services, and Evernorth Health Services, which offers pharmacy, care delivery and health benefits solutions.

Evernorth includes Express Scripts, a pharmacy benefit services provider that manages prescription drug benefits and operates home delivery and specialty pharmacy services.